These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3295811)

  • 21. [Effect and tolerability of Viskaldix retard in ambulatory hypertensive patients].
    Kredel L
    Med Welt; 1984 Feb; 35(5):156-9. PubMed ID: 6366438
    [No Abstract]   [Full Text] [Related]  

  • 22. [Viskaldix for treatment of patients with moderate arterial hypertension. Comparative estimation of hemodynamic changes during treatment with Viskaldix and Stresson].
    Grajek S; Szymczyńska A; Urbański K; Lehman Z; Kozłowska F; Paradowski S; Gracz M
    Kardiol Pol; 1986; 29(7):440-53. PubMed ID: 2879953
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of essential hypertension with Viskaldix].
    Gerc V; Numić N
    Lijec Vjesn; 1984; 106(11-12):515-7. PubMed ID: 6521607
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antihypertensive properties of a beta blocking agent, pindolol].
    Safar M; Weiss Y; Sobel A; Lagrue G; Milliez P
    Nouv Presse Med; 1973 Nov; 2(40):2685-8. PubMed ID: 4586561
    [No Abstract]   [Full Text] [Related]  

  • 25. [Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)].
    Faupel RP; Gotzen R
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1602-5. PubMed ID: 100301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA; Iverson MT
    Arq Bras Cardiol; 1984 Jun; 42(6):435-41. PubMed ID: 6393921
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term Viskaldix therapy in the treatment of hypertensive patients.
    Dudás M; Iványi J
    Ther Hung; 1985; 33(3):152-5. PubMed ID: 3842011
    [No Abstract]   [Full Text] [Related]  

  • 28. Observations with Viskaldix, a combined antihypertensive agent.
    Gyimesi A; Hanyec V; Pocsay G; Lörinczy E; Iványi J
    Ther Hung; 1987; 35(3):147-51. PubMed ID: 3326209
    [No Abstract]   [Full Text] [Related]  

  • 29. The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).
    Persson I
    Eur J Clin Pharmacol; 1977 Jul; 11(6):419-21. PubMed ID: 330169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of hemodynamic changes in patients with primary arterial hypertension after treatment with a combination of pindolol and clopamide (Viskaldix)].
    Wyrzykowski B; Suchecka-Rachoń K
    Kardiol Pol; 1991; 34(5):286-91. PubMed ID: 1921111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of mild and moderate hypertension with viskaldix (author's transl)].
    Voges D; Fryda-Kaurimsky Z
    Schweiz Rundsch Med Prax; 1978 Oct; 67(42):1554-7. PubMed ID: 704550
    [No Abstract]   [Full Text] [Related]  

  • 32. [Viskaldix in the treatment of arterial hypertension].
    Radeva N; Pasheva V; Nachev Ch
    Vutr Boles; 1982; 21(2):117-21. PubMed ID: 7101879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of arterial hypertension with a combination of pindolol and clopamide in long-term use (personal experience)].
    Sivacki J; Mostovac B; Uchytil R
    Lijec Vjesn; 1984; 106(11-12):509-12. PubMed ID: 6394938
    [No Abstract]   [Full Text] [Related]  

  • 34. [Should elderly hypertensive patients be treated with a beta-blocker-diuretic combination?].
    Böhmer F
    Z Gerontol; 1984; 17(2):89-92. PubMed ID: 6730636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].
    Werning C; Hammerschmidt D; Kaiser Hj
    Med Welt; 1978 Oct; 29(40):1570-5. PubMed ID: 703579
    [No Abstract]   [Full Text] [Related]  

  • 36. New design for clinical trial of antihypertensive drugs applied to pindolol, clopamide, and combinations thereof.
    Nyberg G; Asplund J; Anagreus N; Aström B; Leppert J; Bergström R; Overmo J; Kullman S; Lessem J
    Lancet; 1982 Feb; 1(8268):355-8. PubMed ID: 6120347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
    Gábor G; Jávor T; Szám I; Török E
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1853-6. PubMed ID: 811982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-years' study with a combination of pindolol and clopamide ('Viskaldix') in patients with moderate hypertension.
    Török E; Wagner M; Erdélyi M; Maklári E
    Curr Med Res Opin; 1979; 6(3):193-200. PubMed ID: 520024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multi-centre general practice trial of a pindolol/clopamide combination ('Viskaldix') in essential hypertension.
    Crowder D; Cameron EG
    Curr Med Res Opin; 1979; 6(5):342-50. PubMed ID: 396110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pindolol, or a pindolol/clopamide combination preparation, on plasma lipid levels in essential hypertension. Hunter Hypertension Research Group.
    Med J Aust; 1989 Jun; 150(11):646, 648, 651-2. PubMed ID: 2657348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.